Home › NDC Lookup › RxCUI directory › RxCUI 1293862

Ergotamine tartrate 2 MG Sublingual Tablet — RxCUI 1293862

RxNorm drug concept · Semantic clinical drug
RxCUI 1293862 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1293862
Official nameErgotamine tartrate 2 MG Sublingual Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)195 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Ergotamine tartrate 2 MG Sublingual Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ergotamine tartrate 2 MG Sublingual Tablet RxCUI 1293862

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Ergotamine 4025
    • Ergotamine tartrate 42676
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Ergomar 203328
  3. Dose forms 17

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ergotamine Sublingual Tablet 372052
    • Ergotamine tartrate Sublingual Tablet 2646181
    • Ergotamine Oral Product 1164489
    • Ergotamine Pill 1164490
    • Ergotamine Sublingual Product 1295050
    • Ergotamine tartrate Oral Product 2659201
    • Ergotamine tartrate Pill 2661617
    • Ergotamine tartrate Sublingual Product 2659112
    • +9 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 23 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ergotamine tartrate 2 MG SCDC · 1293507
  • Ergotamine Sublingual Tablet SCDF · 372052
  • Ergotamine tartrate Sublingual Tablet SCDFP · 2646181
  • Ergotamine Oral Product SCDG · 1164489
  • Ergotamine Pill SCDG · 1164490
  • Ergotamine Sublingual Product SCDG · 1295050
  • Ergotamine tartrate Oral Product SCDGP · 2659201
  • Ergotamine tartrate Pill SCDGP · 2661617
  • Ergotamine tartrate Sublingual Product SCDGP · 2659112

Brand-Name Concepts

  • Ergotamine tartrate 2 MG Sublingual Tablet [Ergomar] SBD · 1293864
  • Ergotamine tartrate 2 MG [Ergomar] SBDC · 1293863
  • Ergotamine Sublingual Tablet [Ergomar] SBDF · 405974
  • Ergotamine tartrate Sublingual Tablet [Ergomar] SBDFP · 2656253
  • Ergomar Oral Product SBDG · 1168284
  • Ergomar Pill SBDG · 1168285
  • Ergomar Sublingual Product SBDG · 1296940
  • Ergomar BN · 203328

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 1293862 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
81279-0104-03 1 BLISTER PACK in 1 CARTON (81279-104-03) / 3 TABLET in 1 B... Ergomar Sublingual Pangea Pharmaceuticals LLC 2025-02-03
81279-0104-20 2 BLISTER PACK in 1 CARTON (81279-104-20) / 10 TABLET in 1... Ergomar Sublingual Pangea Pharmaceuticals LLC 2025-02-03
Observed labelers: Pangea Pharmaceuticals LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$42.7664
Range $42.7664–$42.7664 · middle 50% $42.7664–$42.7664 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.